Cargando…

In Silico Drug Discovery Strategies Identified ADMET Properties of Decoquinate RMB041 and Its Potential Drug Targets against Mycobacterium tuberculosis

The highly adaptive cellular response of Mycobacterium tuberculosis to various antibiotics and the high costs for clinical trials, hampers the development of novel antimicrobial agents with improved efficacy and safety. Subsequently, in silico drug screening methods are more commonly being used for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knoll, Kirsten E., van der Walt, Mietha M., Loots, Du Toit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045315/ https://www.ncbi.nlm.nih.gov/pubmed/35352998 http://dx.doi.org/10.1128/spectrum.02315-21

Ejemplares similares

Elucidating the Antimycobacterial Mechanism of Action of Decoquinate Derivative RMB041 Using Metabolomics
por: Knoll, Kirsten E., et al.
Publicado: (2021)

Structure-based in silico approaches for drug discovery against Mycobacterium tuberculosis
por: Kingdon, Alexander D.H., et al.
Publicado: (2021)

In Silico Strategies in Tuberculosis Drug Discovery
por: Macalino, Stephani Joy Y., et al.
Publicado: (2020)

The Use of Functional Genomics in Conjunction with Metabolomics for Mycobacterium tuberculosis Research
por: Swanepoel, Conrad C., et al.
Publicado: (2014)

Safety and efficacy of Deccox(®) (decoquinate) for chickens for fattening
por: Bampidis, Vasileios, et al.
Publicado: (2019)

Dim Sum Bonds: The Offshore Renminbi (RMB)-Denominated Bonds
por: Fung, Hung-Gay
Publicado: (2014)

Economic Transformation and Security Analysis of RMB Integration Based on CNN
por: Gong, Liming
Publicado: (2022)

The evaluation of ADME and pharmacokinetic properties of decoquinate derivatives for the treatment of malaria
por: Watson, Daniel J., et al.
Publicado: (2022)

An in silico evaluation of the ADMET profile of the StreptomeDB database
por: Ntie-Kang, Fidele
Publicado: (2013)

How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery
por: Bhagwat, Amala, et al.
Publicado: (2022)

Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening
por: Grzelak, Edyta M., et al.
Publicado: (2019)

Drug Discovery for Mycobacterium tuberculosis Using Structure-Based Computer-Aided Drug Design Approach
por: Ejalonibu, Murtala A., et al.
Publicado: (2021)

In silico Study of Antiviral Activity of Polyphenol Compounds from Ocimum basilicum by Molecular Docking, ADMET, and Drug-Likeness Analysis
por: Kurnia, Dikdik, et al.
Publicado: (2023)

ADMET evaluation in drug discovery. 20. Prediction of breast cancer resistance protein inhibition through machine learning
por: Jiang, Dejun, et al.
Publicado: (2020)

An in vitro ADME and in vivo Pharmacokinetic Study of Novel TB-Active Decoquinate Derivatives
por: Tanner, Lloyd, et al.
Publicado: (2019)

Decoquinate liposomes: highly effective clearance of Plasmodium parasites causing severe malaria
por: Zeng, Sumei, et al.
Publicado: (2022)

In Silico Drug Repurposing Approach: Investigation of Mycobacterium tuberculosis FadD32 Targeted by FDA-Approved Drugs
por: Ngidi, Nolwazi Thobeka Portia, et al.
Publicado: (2022)

Research on Risk Assessment and Prediction of RMB Internationalization Based on the PCA-SA-BPNN Model
por: Hu, Shili, et al.
Publicado: (2022)

Phenotypic and genomic comparison of Mycobacterium aurum and surrogate model species to Mycobacterium tuberculosis: implications for drug discovery
por: Namouchi, Amine, et al.
Publicado: (2017)

Recent Advances of DprE1 Inhibitors against Mycobacterium tuberculosis: Computational Analysis of Physicochemical and ADMET Properties
por: Amado, Patrícia S. M., et al.
Publicado: (2022)

A Chemical Genomic Analysis of Decoquinate, a Plasmodium falciparum Cytochrome b Inhibitor
por: Nam, Tae-gyu, et al.
Publicado: (2011)

Chemical and Pharmacological Properties of Decoquinate: A Review of Its Pharmaceutical Potential and Future Perspectives
por: Souza, Tainá Santos, et al.
Publicado: (2022)

Qualitative and Quantitative Determination of Decoquinate in Chicken Tissues by Gas Chromatography Tandem Mass Spectrometry
por: Liu, Shuyu, et al.
Publicado: (2023)

Pangenome Analysis of Mycobacterium tuberculosis Reveals Core-Drug Targets and Screening of Promising Lead Compounds for Drug Discovery
por: Dar, Hamza Arshad, et al.
Publicado: (2020)

Mycobacterium tuberculosis H37Rv: In Silico Drug Targets Identification by Metabolic Pathways Analysis
por: Amir, Asad, et al.
Publicado: (2014)

Targeting Energy Metabolism in Mycobacterium tuberculosis, a New Paradigm in Antimycobacterial Drug Discovery
por: Bald, Dirk, et al.
Publicado: (2017)

Editorial: In silico Methods for Drug Design and Discovery
por: Brogi, Simone, et al.
Publicado: (2020)

DrugBank: a comprehensive resource for in silico drug discovery and exploration
por: Wishart, David S., et al.
Publicado: (2006)

Pyridine-N-Oxide Alkaloids from Allium stipitatum and Their Synthetic Disulfide Analogs as Potential Drug Candidates against Mycobacterium tuberculosis: A Molecular Docking, QSBAR, and ADMET Prediction Approach
por: Amengor, Cedric Dzidzor Kodjo, et al.
Publicado: (2022)

Efficacy of the feed additive consisting of decoquinate (Deccox(®)) for use in chickens for fattening (Zoetis Belgium SA)
por: Bampidis, Vasileios, et al.
Publicado: (2021)

Preliminary Assessment of Intramuscular Depot of Lipid-Based Decoquinate Formulation for Long-Term Chemoprophylaxis of Malaria
por: Fan, Yinzhou, et al.
Publicado: (2022)

Bioenergetics of Mycobacterium: An Emerging Landscape for Drug Discovery
por: Iqbal, Iram Khan, et al.
Publicado: (2018)

Structure based drug discovery for designing leads for the non-toxic metabolic targets in multi drug resistant Mycobacterium tuberculosis
por: Kaur, Divneet, et al.
Publicado: (2017)

ADMET evaluation in drug discovery: 15. Accurate prediction of rat oral acute toxicity using relevance vector machine and consensus modeling
por: Lei, Tailong, et al.
Publicado: (2016)

Mycobacterium tuberculosis Drug Resistance, Ghana
por: Owusu-Dabo, Ellis, et al.
Publicado: (2006)

Mycobacterium tuberculosis Drug Resistance, Abkhazia
por: Pardini, Manuela, et al.
Publicado: (2005)

Drug-resistant Mycobacterium tuberculosis, Taiwan
por: Jou, Ruwen, et al.
Publicado: (2006)

Drug Resistance Mechanisms in Mycobacterium tuberculosis
por: Palomino, Juan Carlos, et al.
Publicado: (2014)

The road to drug resistance in Mycobacterium tuberculosis
por: Koch, Anastasia, et al.
Publicado: (2014)

Editorial: Drug-resistant Mycobacterium tuberculosis
por: Boshoff, Helena I. M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_717r4mk5cr4hcvp2p0nsq60pmh